042520 — HANS BIOMED Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapFalling Star

Market Cap
KR₩154bn
Enterprise Value
KR₩178bn
Revenue
KR₩78bn

Annual balance sheet for HANS BIOMED, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	26,705	23,567	20,268	14,980	7,048
Net Total Accounts Receivable
Net Total Receivables	14,874	15,526	9,983	10,529	13,114
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	58,785	58,696	51,113	54,371	50,393
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	44,535	47,247	46,591	46,934	44,234
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	134,095	131,806	129,445	131,686	122,368
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24,177	28,092	60,991	74,443	65,253
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	59,213	71,470	84,994	86,052	73,239
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	74,882	60,336	44,451	45,634	49,129
Total Liabilities & Shareholders' Equity	134,095	131,806	129,445	131,686	122,368
Total Common Shares Outstanding